Thinking straight about orphan drugs, Part 4.
Nicholas Bagley September 14, 2016
Even if the Orphan Drug Act were working properly, its enormous costs might outweigh its exiguous benefits. But it’s not working properly. Drug manufacturers are
The Incidental Economist
the health services research blog
Boston-area website management by BKJ Productions